MALACRIDA, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 2.899
EU - Europa 1.956
AS - Asia 1.112
SA - Sud America 179
AF - Africa 33
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.188
Nazione #
US - Stati Uniti d'America 2.852
SG - Singapore 567
IT - Italia 520
DE - Germania 420
RU - Federazione Russa 342
CN - Cina 197
SE - Svezia 173
BR - Brasile 168
IE - Irlanda 128
HK - Hong Kong 104
AT - Austria 89
ID - Indonesia 80
GB - Regno Unito 67
UA - Ucraina 47
DK - Danimarca 43
IN - India 41
CA - Canada 39
FR - Francia 30
FI - Finlandia 27
JP - Giappone 20
NL - Olanda 20
VN - Vietnam 20
BE - Belgio 17
KR - Corea 14
TW - Taiwan 12
TR - Turchia 11
EG - Egitto 8
MX - Messico 7
ZA - Sudafrica 7
BD - Bangladesh 6
EC - Ecuador 6
AU - Australia 5
CZ - Repubblica Ceca 5
MY - Malesia 5
SA - Arabia Saudita 5
ES - Italia 4
EU - Europa 4
GR - Grecia 4
MA - Marocco 4
PK - Pakistan 4
RO - Romania 4
UG - Uganda 4
BG - Bulgaria 3
CH - Svizzera 3
IQ - Iraq 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AO - Angola 2
AR - Argentina 2
CL - Cile 2
HU - Ungheria 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LY - Libia 2
NG - Nigeria 2
PL - Polonia 2
AZ - Azerbaigian 1
BH - Bahrain 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 6.188
Città #
Ann Arbor 1.167
Singapore 377
Frankfurt am Main 337
Wilmington 197
Milan 187
Chandler 154
Fairfield 128
Dublin 126
Hong Kong 101
Ashburn 96
Santa Clara 90
Vienna 81
Woodbridge 78
Dearborn 67
Jakarta 64
New York 63
Boardman 60
Princeton 54
Houston 48
Shanghai 39
Cambridge 37
Jacksonville 33
Seattle 33
Nanjing 23
Pune 22
Appiano Gentile 19
Chicago 19
Beijing 17
Rome 17
Brussels 16
Lawrence 16
Los Angeles 16
Nuremberg 16
Helsinki 15
Moscow 15
San Diego 14
Council Bluffs 13
Florence 12
London 12
Altamura 11
Melzo 11
Nanchang 11
São Paulo 11
Fremont 10
Hangzhou 10
Pavia 10
Andover 8
Brasília 8
Como 8
Düsseldorf 8
Tianjin 8
Edmonton 7
Lappeenranta 7
Romola 7
Shenyang 7
Belo Horizonte 6
Buffalo 6
Jinan 6
Kunming 6
Mountain View 6
Ottawa 6
Rio de Janeiro 6
Tokyo 6
Yogyakarta 6
Bergamo 5
Cagliari 5
Desio 5
Guelph 5
Lanoraie 5
Mainz 5
Ningbo 5
Assago 4
Cairo 4
Dallas 4
Dong Ket 4
Fortaleza 4
Fukuoka 4
Giwangan 4
Guadalajara 4
Guangzhou 4
Hebei 4
Jiaxing 4
Kaohsiung City 4
Kiev 4
Lachine 4
Lauterbourg 4
Quito 4
Seregno 4
Sesto San Giovanni 4
Shah Alam 4
Toronto 4
Torre a Mare 4
Varese 4
Washington 4
Zhengzhou 4
Athens 3
Brno 3
Carate Brianza 3
Changsha 3
Chennai 3
Totale 4.221
Nome #
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 320
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 309
EVALUATION OF ANTITUMORAL EFFECTS OF HIBISCUS SABDARIFFA ON MULTIPLE MYELOMA CELLS 285
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 268
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 265
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 260
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 251
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 235
Are sigma receptor modulators a weapon against multiple sclerosis disease? 226
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 224
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 220
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 209
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 208
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 191
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 174
Evaluation of in vitro antitumoral activity and neurotoxicity of a Hibiscus Sabdariffa ethyl acetate fraction against human multiple myeloma cells 174
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 168
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 149
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 147
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 140
Antitumoral effects of Hibiscus Sabdarifa on human oral squamous cell carcinoma and multiple myeloma cells 137
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 134
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 131
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 127
Rigosertib and cholangiocarcinoma: A cell cycle affair 118
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 115
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 113
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells 102
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent 101
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 100
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 99
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 97
In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells 93
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 92
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 78
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells 70
RICOLINOSTAT INDUCES MICROTUBULE ACETYLATION AND NEURITE REGENERATION IN CELLULAR MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHY 67
The Role of NMNAT2/SARM1 in Neuropathy Development 65
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 63
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 58
Neurodegeneration: can metabolites from Eremurus persicus help? 56
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 51
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES 48
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa—part 2 48
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 45
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 41
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 41
Totale 6.713
Categoria #
all - tutte 25.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020168 0 0 0 0 0 0 0 0 0 81 77 10
2020/20211.175 24 41 115 140 101 118 135 130 102 69 92 108
2021/2022643 63 92 77 53 42 56 30 30 20 25 50 105
2022/20231.012 94 221 158 88 80 121 31 63 55 21 52 28
2023/2024668 24 23 31 23 65 138 91 37 48 21 7 160
2024/20252.046 183 175 189 134 263 180 188 90 296 348 0 0
Totale 6.713